SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-308476
Filing Date
2014-08-13
Accepted
2014-08-13 16:34:52
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d726474d10q.htm 10-Q 214722
2 CERTIFICATION d726474dex311.htm EX-31.1 6033
3 CERTIFICATION d726474dex312.htm EX-31.2 6036
4 CERTIFICATION d726474dex321.htm EX-32.1 2740
5 CERTIFICATION d726474dex322.htm EX-32.2 2742
  Complete submission text file 0001193125-14-308476.txt   2126162

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20140630.xml EX-101.INS 166258
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20140630.xsd EX-101.SCH 31873
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20140630_cal.xml EX-101.CAL 24732
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20140630_def.xml EX-101.DEF 123850
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20140630_lab.xml EX-101.LAB 235060
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20140630_pre.xml EX-101.PRE 159856
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 141037925
SIC: 8731 Services-Commercial Physical & Biological Research